Biocellvia retweeted
Vous pouvez toujours investir dans la startup @Biocellvia, découvrez le dernier article des @LesEchos sur cette #biotech
#startup #entrepreneuriat #crowdfunding
Replying to @LesEchos
@LesEchos parlent de nous ! Ils mettent en avant notre technologie et parlent de son succès mondial. Pour les #investisseurs intéressés, nous sommes toujours en levée de fonds. C'est ici que ça se passe : sowefund.com/projet/69/bioce…
Biocellvia retweeted
ELPA president @Marko_Korenjak is part of Paris #NASH meeting. He will address to the participants in panel 1, session 1 on patient view of #NAFLD and #NASH. @NASH_Education @intNASHday @nash24x7 @EU_Health @WHO_Europe
Biocellvia retweeted
Prof. Serfaty addressing the participants of Paris
#NASHmeeting. @Marko_Korenjak #NAFLD #NASH. @NASH_Education @intNASHday @nash24x7 @EU_Health @WHO_Europe
Biocellvia retweeted
Replying to @phil_newsome7
@phil_newsome7 describing strategies to treat Liver fibrosis. So many similarities with trying to #CureIPF. List of current therapies being tried in NASH & NAFLD. ?roles in #IPF. Also more good news about #coffee!
Thanks a lot @cci_paca for this nice article about @Biocellvia
#startup #medtech #biotech #technology #innovation #science #biology #invest #investment #equity #crowdequity
[ACTU] #SuccessStory : au moment où la #TeamFranceExport en #regionSud lance le Business Starter 2019 à San Francisco & San Diego, Olivier Julé, CEO de @Biocellvia réalise son rêve californien paca.cci.fr/r-7903 #MedTech #BioTech #International
1
On this International NASH Day, Biocellvia wants to highlight its own involvment in the research to fight this disease.
More info on : lnkd.in/gRvWq6F
#NASH #NASHdisease #InternationalNASHday #NAFLD #NASHday #liver #biotech #medtech #pharma #obesity #diabete #startup
We are doing a NASH quantitative analysis by quantifying with considerable accuracy the three key parameters of this pathology: steatosis, fibrosis and inflammation.
More info on : biocellvia.com
#EASL #AASLD #ILC2019 #NASH #NAFLD #steatosis #fibrosis #inflammation
Our article on the digital analysis of Idiopathic Pulmonary Fibrosis (IPF) is often quoted. There has been a significant impact which is yet another sign the scientific community is interested in our technology.
More info on : lnkd.in/gD5CVFS
1
Thanks a lot @EnyoPharma
Biocellvia met today leaders from Californian pharma companies. That was a great moment ! #innovation #tech #pharma #startup #medtech #biotech #histology #digital #image #analysis #health
[ #SudBusinessTour #Provence ] Entreprises et acteurs économiques de Californie découvrent l'écosystème de l’#innovation de la métropole Aix-Marseille Provence En visite depuis plusieurs jours sur la région Sud, ils seront demain à Marseille. https://xitter.cf/t.co/TJ7n0hbS7b
1
Biocellvia retweeted
Rejoignez l'aventure @Biocellvia et investissez à partir de 100€ dans cette #startup #biotech sur @sowefund : urlz.fr/97jK
You can invest in Biocellvia with Sowefund by clicking here : sowefund.com/projet/69/bioce…
#crowdequity #fundraising #crowdfunding #funding #startup #biotech #medtech #pharma #frenchtech #tech
You can invest in Biocellvia with Sowefund by clicking here : sowefund.com/projet/69/bioce…
#crowdequity #fundraising #crowdfunding #funding #startup #biotech #medtech #pharma #frenchtech #tech
We’ve already announced three new references since the beginning of the year... And there’s more coming!
lnkd.in/gqxp2cK
2
Olivier Julé presented yesterday Biocellvia's fundraising activity in Paris in front of dozens of investors and business angels.
To invest in Biocellvia : lnkd.in/gdbvkgR
#startup #fundraising #equity #crowdequity #crowdfunding #invest #investment #biotech #medtech
3
That's great news for us ! Discover our other public references by clicking on the picture : biocellvia.com/references
#reference #startup #biotech #medtech #NASH #NAFLD #NashSummit #EASL #ILC2019 #pharma #liver #disease
Biocellvia retweeted
I’ll be speaking today at #NASHSummit in Boston on “Understanding HCC as an extension of NASH: practical implications for drug development”. Hope to see some of you there! #HCC #NASH






























